<SEC-DOCUMENT>0001558370-24-004997.txt : 20240412
<SEC-HEADER>0001558370-24-004997.hdr.sgml : 20240412
<ACCEPTANCE-DATETIME>20240412080549
ACCESSION NUMBER:		0001558370-24-004997
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240410
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240412
DATE AS OF CHANGE:		20240412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		24840030

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>adap-20240410x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.5.0.8 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 4/12/2024 10:06:46 AM -->
<!-- iXBRL Library version: 1.0.8703.18788 -->
<!-- iXBRL Service Job ID: e166e094-b53f-420d-b33b-47aa2189b7a4 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:adap="http://www.adaptimmune.com/20240410" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityCentralIndexKey" id="Tc_VCq8lNSDiUmxMHEkgBbWZw_2_1">0001621227</ix:nonNumeric><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:AmendmentFlag" id="Tc_9HsRJ4vP_kylrnWKS3tfKw_3_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityTaxIdentificationNumber" id="Hidden_Atyi2nd1DEK5OzE7k3nwKQ">00-0000000</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="adap-20240410.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001621227</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-10</xbrli:startDate><xbrli:endDate>2024-04-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_7496f995_a2ab_489f_8c05_ca9df3b19c92"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES </b><b style="font-size:18pt;font-weight:bold;"><br/></b><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:DocumentType" id="Narr_rYxStbbiUU-_nVPpnd_qUw"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Current Report</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported):<b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_PATE4kXuPUaaH0NuFyWrIA"><b style="font-weight:bold;">April 10, 2024</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityRegistrantName" id="Narr_yghOj7fz2E6bjfE4C5tGVw"><b style="font-weight:bold;">ADAPTIMMUNE THERAPEUTICS PLC</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a955ef0e_e52b_4858_9ce4_6782eccbb535"></a><a id="Tc_ucvypdc4L0yQ8lHzJCX_GQ_2_0"></a><a id="Tc_y7jiPoQooUu4LQsWWwJHQw_2_2"></a><a id="Tc_i95-JHwjw0GJsJb8KN506Q_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="Tc_pF8UPsfn80KkJGV0uxCBcw_1_0"><b style="font-weight:bold;">England and Wales</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityFileNumber" id="Tc_t6IlSu4cBUGLfeCVPHXzzA_1_2"><b style="font-weight:bold;">1-37368</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_Atyi2nd1DEK5OzE7k3nwKQ;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Not Applicable</b></span></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or other jurisdiction of<br/>incorporation)</p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityAddressAddressLine1" id="Narr_sern7sp-GE2X2kXiTT1Bcg"><b style="font-weight:bold;">60 Jubilee Avenue</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityAddressAddressLine2" id="Narr_BZQnxsqCYU2yvD2ZN9-NHA"><b style="font-weight:bold;">Milton Park</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityAddressCityOrTown" id="Narr_wM6RthVKF0ObxYOAVJub9g"><b style="font-weight:bold;">Abingdon, Oxfordshire</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:EntityAddressPostalZipCode" id="Narr_jOZRTQNmvUqSb5f6MNKohg"><b style="font-weight:bold;">OX14 4RX</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="Narr_xKOSlKNREU2JmbQzmvrtOQ"><b style="font-weight:bold;">United Kingdom</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Address of principal executive offices, including zip code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:CityAreaCode" id="Narr_GsLLTFByTE24w_m4YVl--A"><b style="font-weight:bold;">44</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:LocalPhoneNumber" id="Narr_2QsK3EiLlk-5Th3iGGux7g"><b style="font-weight:bold;">1235 430000</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_rn4D_lW8BkikFGvM6naiAA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_yhjziRn64E-XX0cIoGernw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_H6hPAsf5H0-6ENfRT4A_hA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_d856zkyArkGKbDbJaQcQjw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_602dac61_edc2_4936_8590_9ecf753fb00c"></a><a id="Tc_3j7FaPRDEEqqfg2NZ2gQfQ_0_0"></a><a id="Tc_MJvW5HGNs0GeWLRxJY_-Lg_0_2"></a><a id="Tc_cZTf7hEHe0-wJb3DXm1flA_0_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title&#160;of&#160;each&#160;class</b></p></td><td style="vertical-align:bottom;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading&#160;Symbol</b></p></td><td style="vertical-align:bottom;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">registered</b></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:Security12bTitle" id="Tc_oOkxOzD_Mk2Rjk_AP8pU_g_1_0">American Depositary Shares, each representing 6 Ordinary Shares, par value &#163;0.001 per share</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" name="dei:TradingSymbol" id="Tc_ciq7Zn38OE-ZuESo6kPbOQ_1_2">ADAP</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_P2pznlksk0umGKKHw8FyDw_1_4">The Nasdaq Global Select Market</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 18pt 0pt 0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_2vVuJGof60-_WtIky9UcBg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_067fba00_e8e9_4345_b46d_0fe0fabbbdb3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Item 1.02   Termination of Material Definitive Agreement.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:14pt 0pt 0pt 0pt;">On April 10, 2024, Adaptimmune Limited, a wholly-owned subsidiary of Adaptimmune Therapeutics plc (&#8220;Adaptimmune&#8221;) received notice of termination of the Strategic Collaboration and License Agreement with Genentech, Inc. (&#8220;Genentech&#8221;) and F. Hoffman-La Roche Ltd. (the &#8220;Agreement&#8221;). &#160;The termination will become effective 180 days after the date of receipt of the notice of termination (the &#8220;Termination Date&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">Under the Agreement, Genentech and Adaptimmune (each, a &#8220;party&#8221; and together, the &#8220;parties&#8221;) collaborated to develop two types of allogeneic T-cell therapies: (i) off-the-shelf &#945;&#946; T-cell therapies directed to up to five collaboration targets and (ii) personalized therapies utilizing &#945;&#946; T-cell receptors (TCRs) isolated from a patient, with these therapies being administered to the same patient. Under the terms of the Agreement, Adaptimmune received $150 million in upfront payments and $35 million in milestone payments. Until the Termination Date, the obligations of the parties under the Agreement will continue as currently provided.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">As a result of the termination of the Agreement, Adaptimmune will not be entitled to receive any further milestones or other payments due after the Termination Date. Adaptimmune will also cease to have any development obligations after the Termination Date and the licenses Adaptimmune granted to Genentech pursuant to the Agreement will cease to be in effect as of the Termination Date. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;"><span style="background:#ffffff;">The foregoing description of the termination of the Agreement is only a summary of the material terms thereof, and does not purport to be complete. The description is qualified in its entirety by reference to the Agreement, which was filed as Exhibit 10.1 to Adaptimmune&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 4, 2021 and is attached as Exhibit 10.1 hereto and incorporated herein by reference</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">On April 12, 2024, Adaptimmune issued a press release announcing the termination of the Agreement. A copy of the press release is being filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">(d)&#160; Exhibits.</p><div style="padding-left:36pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:86%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:12.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;margin:0pt;"><b style="font-weight:bold;">Exhibit&#160;No.</b></p></td><td style="vertical-align:bottom;width:2.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description&#160;of&#160;Exhibit</b></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;">10.1&#8224;</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="https://www.sec.gov/Archives/edgar/data/1621227/000155837021014594/adap-20210930xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Strategic Collaboration and License Agreement among Adaptimmune Limited, on the one hand, and Genentech, Inc. and F. Hoffman-La Roche Ltd, on the other hand, made and entered into as of September 3, 2021 (incorporated by reference to Exhibit 10.1 to Adaptimmune&#8217;s Quarterly Report on Form 10-Q filed on November 4, 2021).</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="adap-20240410xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release dated April 12, 2024</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;">Cover Page Interactive Date File (embedded within the Inline XBRL document)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;background:#ffffff;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:3.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:middle;width:96.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:3.62%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">&#8224;</p></td><td style="vertical-align:middle;width:96.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Certain portions of this exhibit have been omitted because they are not material and they are the type of information that the registrant treats as private or confidential.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ADAPTIMMUNE THERAPEUTICS PLC</p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date:April 12, 2024</p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Margaret Henry</p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Margaret Henry</p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Corporate Secretary</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>adap-20240410xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 4/12/2024 10:06:45 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><font style="color:#ffffff;"><img src="adap-20240410xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:23.94pt;width:149.62pt;"></font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt 0pt 8pt 0pt;"><font style="font-size:10pt;font-weight:bold;line-height:1.28;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 6pt 0pt;"><font style="font-size:12pt;">Company remains focused on launching afami-cel later this year with a PDUFA date of August&#160;4</font><sup style="font-size:9pt;vertical-align:top;">th</sup><font style="font-size:12pt;"> and developing its broader sarcoma franchise</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 6pt 0pt;"><font style="font-size:12pt;">Update on afami-cel launch plans to be provided at the April 18</font><sup style="font-size:9pt;vertical-align:top;">th</sup><font style="font-size:12pt;"> Investor Day</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 6pt 0pt;"><b style="font-size:12pt;font-weight:bold;">PHILADELPHIA, PA. and OXFORD, UK, April 12</b><b style="font-size:12pt;font-weight:bold;background:#ffffff;">, 2024</b><font style="font-size:12pt;background:#ffffff;"> &#8211; Adaptimmune Therapeutics plc&#160;(Nasdaq:&#160;ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that its strategic collaboration with Gen</font><font style="font-size:12pt;">entech entered in 2021, ha</font><font style="font-size:12pt;background:#ffffff;">s been terminated.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 6pt -1pt;"><b style="font-size:12pt;font-weight:bold;">Adrian Rawcliffe, Adaptimmune&#8217;s Chief Executive Officer:</b><font style="font-size:12pt;"> &#8220;We&#8217;ve had a very valuable collaboration with our partner Genentech, and we continue to believe in the long-term potential of our iPSC-based allogeneic platform. Over the past 12 months, we&#8217;ve been resolutely focused on our late-stage autologous pipeline &#8211; in particular, our sarcoma franchise. We have the resources to deliver afami-cel to market as planned, and I look forward to updating on progress at our Investor Day next week.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:6pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">About Adaptimmune</b><b style="font-size:12pt;font-weight:bold;"><br></b><font style="font-size:12pt;">Adaptimmune is a cell therapy company working to redefine how cancer is treated. With personalized medicines that radically improve the patient&#39;s experience with the therapy as much as the therapy itself, Adaptimmune is tackling difficult-to-treat solid tumor cancers so that patients and families may experience more unforgettable and important personal moments. The Company&#39;s unique engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:6pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Forward-Looking Statements</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">This release contains &quot;forward-looking statements&quot; within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These forward-looking statements involve certain risks and uncertainties. Such risks and uncertainties could cause our actual results to differ materially from those indicated by such forward-looking statements, and include, without limitation: the success, cost and timing of our product development activities and clinical trials and our ability to successfully advance our TCR therapeutic candidates through the regulatory and commercialization processes. For a further description of the risks and uncertainties that could cause our actual results to differ materially from those expressed in these forward-looking statements, as well as risks relating to our business in general, we refer you to our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended 31&#160;December, 2023, our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made and we do not undertake any obligation to update such forward-looking statements to reflect subsequent events or circumstances.</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:6pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Adaptimmune Contact</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:6pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Investor Relations</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">Juli P. Miller, Ph.D. - VP, Corporate Affairs and Investor Relations</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">T : +1 215 825 9310</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">M : +1 215 460 8920</font><font style="font-size:12pt;"><br></font><u style="color:#0033cc;font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;">Juli.Miller@adaptimmune.com</u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:6pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Media Relations</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">Dana Lynch, Senior Director of Corporate Communications</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">M: +1 267 990 1217</font><font style="font-size:12pt;"><br></font><u style="color:#0033cc;font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;">Dana.Lynch@adaptimmune.com</u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;background:#ffffff;margin:0pt 0pt 6pt 0pt;"><font style="color:#4a4a4a;font-size:12pt;background:#e6e6e6;"><img src="adap-20240410xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:24pt;width:150pt;"></font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>adap-20240410xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 adap-20240410xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  P 2P# 2(  A$! Q$!_\0
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MR2.?4FOG3Q!\(_BDG@:+PQ!X3U46TEZ]Q+N48QM&._JM?1?@;XD^*=._9O\
M$'BO7-;GNM0=2VGS.,2*PX(''J#7SKK_ ,7?BD_@:+Q/!XLU7[-'>O;R[B,$
M;1CMZM1+F]G+GV/:R?3%1Y/BZ'MOB#X4^*_#G[*UGX<\/Z1=SZU>E&NK:-0&
M57'[SO4'P.^%_B7X/?!36]2@T"Y?QA=(WV>RV+O4@X'.>XYJ?Q#\5_%?B/\
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M,>LV;B1K@QAL,,<[L5](>.XM6;PAJ-OH$:2:G-"8H2S[0"01N_"H_!O@'0O
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MU3:_X'^*_P 4]&O=/\1-9:3:F([+2V8,)F(Z,PQC\N]?2+(N!]Y\=P:B?#,
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8Z*JY#,NX_P"P33Q"6Y$K*/3%5SLCD/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>adap-20240410xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 adap-20240410xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  @ ,@# 2(  A$! Q$!_\0
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MHVS1O$>F+NEMHO[_ )O\4?\ ]AO2OG<1*4ZTI(_2,LJ8:OA;SC[T8\LOYO\
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COA=X1\)7SWFB>&M)TJ\?_EO:6:1,?^!***M8AI:,CV9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>adap-20240410.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/12/2024 10:06:50 AM-->
<!--Modified on: 4/12/2024 10:06:50 AM-->
<xsd:schema xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:attributeFormDefault="unqualified" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:srt="http://fasb.org/srt/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2023" targetNamespace="http://www.adaptimmune.com/20240410" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:adap="http://www.adaptimmune.com/20240410" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="adap-20240410_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="adap-20240410_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="adap_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>adap-20240410_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/12/2024 10:06:50 AM-->
<!--Modified on: 4/12/2024 10:06:50 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="adap-20240410.xsd#adap_DocumentAndEntityInformationAbstract" xlink:label="adap_DocumentAndEntityInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="adap_DocumentAndEntityInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="adap_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Country</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>adap-20240410_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/12/2024 10:06:50 AM-->
<!--Modified on: 4/12/2024 10:06:50 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="adap-20240410.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="adap-20240410.xsd#adap_DocumentAndEntityInformationAbstract" xlink:label="adap_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638485132103200635" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_638485132103200635" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638485132103200635" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_638485132103200635" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638485132103200635" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFileNumber_638485132103200635" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638485132103200635" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_638485132103200635" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638485132103200635" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638485132103200635" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638485132103200635" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638485132103200635" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine1_638485132103210618" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine2_638485132103210618" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCityOrTown_638485132103210618" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressPostalZipCode_638485132103210618" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCountry_638485132103210618" order="11" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_CityAreaCode_638485132103210618" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_LocalPhoneNumber_638485132103210618" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_WrittenCommunications_638485132103210618" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_SolicitingMaterial_638485132103210618" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementTenderOffer_638485132103210618" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638485132103210618" order="17" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638485132103210618" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_Security12bTitle_638485132103210618" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638485132103220615" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol_638485132103220615" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638485132103220615" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_SecurityExchangeName_638485132103220615" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638485132103220615" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638485132103220615" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638485132103220615" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_638485132103220615" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638485132103220615" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_638485132103220615" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140042666743104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_adap_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 10,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-37368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADAPTIMMUNE THERAPEUTICS PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">60 Jubilee Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Milton Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Abingdon, Oxfordshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">OX14 4RX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1235 430000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing 6 Ordinary Shares, par value &#163;0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001621227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adap_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adap_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "W0(Q8R)$/J),$  "6$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)V8;W/B-A#&OXK&G>FT,TFP#"%<#IAQ"+FCES\TD%ZFG;X0M@!-;,F5Y4"^
M?5<VL>G$K+GF1;!!>OSS[NI9V?V-TB_IFG-#MG$DTX&S-B:Y;+728,UCEIZI
MA$OX9:ETS R<ZE4K331G83XICEJ>ZW9;,1/2&?;S[Z9ZV%>9B83D4TW2+(Z9
M?KOBD=H,'.J\?_$H5FMCOV@-^PE;\1DW3\E4PUFK5 E%S&4JE"2:+P>.3R^O
MO',[(1_QA^";=.^8V%M9*/5B3R;AP'$M$8]X8*P$@X]7/N)19)6 XY^=J%->
MTT[</WY7O\EO'FYFP5(^4M%W$9KUP.DY).1+ED7F46V^\MT-Y8"!BM+\/]D4
M8SL=AP19:E2\FPP$L9#%)]ON K$WH><>F.#M)G@Y=W&AG/*:&3;L:[4AVHX&
M-7N0WVH^&^"$M%F9&0V_"IAGAM<JR"#(AC 9DK$TPKR1B2RR#5'KMPQ<Q YM
M!3O!JT+0.R#H)_J,4/>$>*[7^>_T%K"5@%X)Z.5Z[?\'2/[R%ZG1D-R_ZU@+
M[4Z]MJWXRS1A 1\X4-(IUZ_<&?[\$^VZGQ'R=DG>QM0K\OE;PNO@\.F]TV\(
M1*>$Z!P',>5:*!O!D$"AU/+@2F5BFS)[7J*=HX*[9-Z(B)/[+%YP70>%:]#3
M]D6[VT-HNB5-]QB:1[X2MIX@8O<LK@T3KN-?^]/YY.[NZ7Y,YE_'C_YT_#2?
MC&9D>CM","]*S(MC,"<R4#I1.E\#)V1F(*5$:3)2F33Z#3[#6G9<_-E%"'LE
M8>\8PCG;DDD(E2>6(BB6ZN$DXXJN>^H6?PC>IQ+OTS%X?AC"BD]/W@_(+8PC
M#[(V:KABUR6_90NH8D[\5RXSCE!2M_)E]P<Y*\SY1M4:,ZYX)R(#69@R_8(1
M[G4.^D.$(WL&-3A7F_J^@<OY"R%7H:WFARW8.^POA$9#6740BMK\!]"I2@V+
MR)\B.;A.&A0?GFF'=!Z?,;RJ35#<Z#_$L5C#M5BXTI<K#*AJ&11W^CR1/NSQ
M#H<'%^A@[8%6_8'BYGZK DC3=*TDUB :1*C7/B>==H-[T*I-4-S?OVMA#)<0
MFCC.Y,[:TEHP7&C)HA2M[ZHE4-RV9RH2@3"P?,@=] $M6%3+@ZLT\E0-@.)^
M/=7\-(#P<!GP8@/$9<@U>5@N#Z00UVLDJ[R?XE;]@6R2IAF0-0+BLDV 7N7Z
M'N[1<V%@-Z26A'J_+'XE,QYD4&^U7M"@Y,=0" &3Y)HG*A4&'KG(;,W 8DX(
M9\$:'JGR/:_,ZZ9+'G0HY/Z@A&GRRJ*,$[LC;G]VSUR7D@3"E-H1V.U6+<3#
M/7^N66@O/WN+%ZJV:!L$[&X+(]E[RL =_3W29+P-UDRN^,'M7X/0O3^[]G_'
MF*K&X!W5&,:0R96-TA=0,&OK/ F3]36!"S;6:=4B/-SA=V@C*!\-'CV!Y;,E
MWW@]%"X%QDR['O6\"XRL:AH>[O=0]S+,U_9-Q%:U/+C P2"U]IZR[1N+.V;3
MDI*(+T'(/;L 75V\!"A.C$KR!^^%,O 8GQ^N.0.CL0/@]Z52YOW$/LN7KV*&
M_P)02P,$%     @ MT",6)^@&_"Q @  X@P   T   !X;"]S='EL97,N>&UL
MW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75E
MW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R
M5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#
M7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%
M8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE
M+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8
M Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL
M_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2S
MP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DM
MC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?
M7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D
M7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$
MKQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3
M\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q
M;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X
M#SY['R73>RHY_U=3_ 102P,$%     @ MT",6)>*NQS     $P(   L   !?
M<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^O
MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ MT",6 =!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "W0(Q8_V3 BN\    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "W0(Q8F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( += C%C(D0^HDP0  )81   8
M      " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "W0(Q8GZ ;\+$"  #B#   #0              @ '7#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( += C%B7BKL<P    !,"   +              "
M ;,/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( += C%@<.&7J/P$  #P"   /
M              "  9P0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "W
M0(Q8)!Z;HJT   #X 0  &@              @ $($@  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "W0(Q899!YDAD!  #/ P  $P
M            @ 'M$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"   W%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="adap-20240410x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>adap-20240410.xsd</File>
    <File>adap-20240410_lab.xml</File>
    <File>adap-20240410_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="adap-20240410x8k.htm">adap-20240410x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "adap-20240410x8k.htm": {
   "nsprefix": "adap",
   "nsuri": "http://www.adaptimmune.com/20240410",
   "dts": {
    "schema": {
     "local": [
      "adap-20240410.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "adap-20240410_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adap-20240410_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "adap-20240410x8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "adap-20240410x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "adap-20240410x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "adap_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adaptimmune.com/20240410",
     "localname": "DocumentAndEntityInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Adress Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001558370-24-004997-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-004997-xbrl.zip
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M5 ++F9VE/<!)H5"C!BW:2Q6(8RNV-V=AL@@7:5N+M#.'YHUMDBRJ(AN+7I9
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M4*W<0-FMHW3EOX[<DUOJ9]SY6WGOF_\ 4$L#!!0    ( += C%@LEW4]CP0
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M]JK-W3JI'1\=-<[/&\=-T>/SZ?EQXIHE]I(&71@)H>MLD.U,+4-4.:^5GYG
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MU2%F'81L$X/8V_R]-&2?% A'>8GX9VC>(^TH=H]Y>DUYQTD$\>);HG]7(O\
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MM7]P;QK'"0G\//YQUCIM]J\O?IWK>:MPU#QPN\LD<'RE:$0[NWIWV)F/F.-
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MO"/9.PT4==<<PZ]NV+>__3]02P,$%     @ MT",6+[#$(C_"0  IB$  !@
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M_.0T(D8E2^F\/X;>99""FH/9J;8!]2"!UJ6^1AN=-?!8>R+RS1ZLEHO@7EJ
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MEC_>GBPTT/! =](-_X#@_Z/AX+]02P$"% ,4    " "W0(Q8/A["/\L#  !
M#0  $0              @ $     861A<"TR,#(T,#0Q,"YX<V102P$"% ,4
M    " "W0(Q8VYBA\98%  "U/@  %0              @ 'Z P  861A<"TR
M,#(T,#0Q,%]L86(N>&UL4$L! A0#%     @ MT",6"R7=3V/!   8"H  !4
M             ( !PPD  &%D87 M,C R-# T,3!?<')E+GAM;%!+ 0(4 Q0
M   ( += C%C'@M=[)1<  *R<   4              "  84.  !A9&%P+3(P
M,C0P-#$P>#AK+FAT;5!+ 0(4 Q0    ( += C%B^PQ"(_PD  *8A   8
M          "  =PE  !A9&%P+3(P,C0P-#$P>&5X.3ED,2YH=&U02P4&
/  4 !0!- 0  $3

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>adap-20240410x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adap-20240410.xsd" xlink:type="simple"/>
    <context id="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001621227</identifier>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_VCq8lNSDiUmxMHEkgBbWZw_2_1">0001621227</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_9HsRJ4vP_kylrnWKS3tfKw_3_1">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Hidden_Atyi2nd1DEK5OzE7k3nwKQ">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_rYxStbbiUU-_nVPpnd_qUw">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_PATE4kXuPUaaH0NuFyWrIA">2024-04-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_yghOj7fz2E6bjfE4C5tGVw">ADAPTIMMUNE THERAPEUTICS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_pF8UPsfn80KkJGV0uxCBcw_1_0">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_t6IlSu4cBUGLfeCVPHXzzA_1_2">1-37368</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_sern7sp-GE2X2kXiTT1Bcg">60 Jubilee Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_BZQnxsqCYU2yvD2ZN9-NHA">Milton Park</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_wM6RthVKF0ObxYOAVJub9g">Abingdon, Oxfordshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_jOZRTQNmvUqSb5f6MNKohg">OX14 4RX</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_xKOSlKNREU2JmbQzmvrtOQ">GB</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_GsLLTFByTE24w_m4YVl--A">44</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_2QsK3EiLlk-5Th3iGGux7g">1235 430000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_rn4D_lW8BkikFGvM6naiAA">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_yhjziRn64E-XX0cIoGernw">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_H6hPAsf5H0-6ENfRT4A_hA">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_d856zkyArkGKbDbJaQcQjw">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_oOkxOzD_Mk2Rjk_AP8pU_g_1_0">American Depositary Shares, each representing 6 Ordinary Shares, par value &#xa3;0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_ciq7Zn38OE-ZuESo6kPbOQ_1_2">ADAP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Tc_P2pznlksk0umGKKHw8FyDw_1_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_4_10_2024_To_4_10_2024_y1zo_m0OHEKIW47A4Urgiw"
      id="Narr_2vVuJGof60-_WtIky9UcBg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
